Loading company…
Bridgewater-based pharmaceutical company developing therapeutics for underserved medical needs.
Tacurion Pharma, Inc. is headquartered in Bridgewater, US, and develops therapeutics for unmet medical needs, with a focus on conditions that have a significant impact on patients. In April 2013, it raised USD 15 mn in Series D funding from investors including Astellas Venture Management, InterWest Partners and Sutter Hill Ventures. The current company valuation is USD 64.39 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in